AGF Management’s Boston Scientific BSX Stock Holding History

AGF Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.06M	Sell	112,483 -1,574,853	-93%	-$126M	0.03%	233
2025 Q4	$161M	Sell	1,687,336 -1,550,646	-48%	-$152M	0.7%	36
2025 Q3	$316M	Buy	3,237,982 +3,360	+0.1%	+$348K	1.39%	15
2025 Q2	$347M	Sell	3,234,622 -1,512,670	-32%	-$153M	1.58%	9
2025 Q1	$479M	Sell	4,747,292 -49,829	-1%	-$5.02M	2.53%	3
2024 Q4	$428M	Sell	4,797,121 -120,000	-2%	-$10.6M	2.13%	6
2024 Q3	$412M	Buy	4,917,121 +69,590	+1%	+$5.49M	2.09%	5
2024 Q2	$373M	Sell	4,847,531 -6,846	-0.1%	-$501K	2.07%	5
2024 Q1	$332M	Sell	4,854,377 -4,441	-0.1%	-$286K	1.84%	5
2023 Q4	$281M	Sell	4,858,818 -20,973	-0.4%	-$1.12M	1.65%	7
2023 Q3	$258M	Buy	4,879,791 +929,763	+24%	+$48.8M	1.83%	4
2023 Q2	$214M	Buy	3,950,028 +1,651,426	+72%	+$86.3M	1.55%	8
2023 Q1	$115M	Buy	2,298,602 +2,262,088	+6,195%	+$107M	0.79%	31
2022 Q4	$1.69M	Buy	+36,514	New	+$1.58M	0.01%	518

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AGF Management's BSX Position: Q1 2026 in Review

AGF Management reduced its Boston Scientific (BSX) stake by 93% in Q1 2026, selling an estimated $126M and leaving 112,483 shares worth $7.06M. The position accounts for 0.03% of the portfolio, ranked #233.

AGF Management first reported a position in BSX in Q4 2022 and has held it in 14 quarters since. The position peaked at $479M in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

AGF Management held 112,483 shares of Boston Scientific worth $7.06M as of Q1 2026.
AGF Management sold 1,574,853 Boston Scientific shares in Q1 2026, an estimated $126M.
Boston Scientific made up 0.03% of AGF Management's portfolio in Q1 2026, its #233 holding.
AGF Management first reported a position in Boston Scientific in Q4 2022 and has held it in 14 quarters since.
AGF Management's Boston Scientific position peaked at $479M in Q1 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on AGF Management's 13F filing for Q1 2026, filed 7 May 2026.